Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2005
07/20/2005EP1554254A1 Novel compounds
07/20/2005EP1554251A1 Process for making pyrazole compounds
07/20/2005EP1554249A2 1-pyridin-4-yl-urea derivatives
07/20/2005EP1554246A2 Dihydropyridinone derivatives as hne inhibitors
07/20/2005EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
07/20/2005EP1554244A1 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
07/20/2005EP1554239A2 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
07/20/2005EP1553949A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
07/20/2005EP1553947A2 Quinazolinones and derivatives thereof as factor xa inhibitors
07/20/2005EP1553931A1 Compounds, compositions, and methods
07/20/2005EP1379511B1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
07/20/2005EP1286673B8 Ligands of integrin receptors
07/20/2005EP1272484B1 Benzoamide piperidine compounds as substance p antagonists
07/20/2005EP1175402B1 Piperidine derivatives useful as ccr5 antagonists
07/20/2005EP1175401B1 Piperazine derivatives useful as ccr5 antagonists
07/20/2005EP1056717B1 Arylphenyl-substituted cyclic keto-enols
07/20/2005CN1643105A Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
07/20/2005CN1642950A 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
07/20/2005CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642943A Synthesis of piperidine and piperazine compounds as CCR5 antagonists
07/20/2005CN1642942A Method for manufacture of sertindole
07/20/2005CN1642941A 1-N-aminobenzimidazole derivatives
07/20/2005CN1642940A Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides
07/20/2005CN1642939A Pyridinoylpiperidines as 5-HTLF agonists
07/20/2005CN1642938A New compounds
07/20/2005CN1642937A Process for making chiral 1, 4-disubstituted piperazines
07/20/2005CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642925A Novel tetrazole derivative useful as herbicides
07/20/2005CN1642924A Anxiolytic agents with reduced sedative and ataxic effects
07/20/2005CN1642922A Substituted indazoles with anti-cancer activity
07/20/2005CN1642921A 5-substituted-alkylaminopyrazole derivatives as pesticides
07/20/2005CN1642920A 5-substituted-alkylaminopyrazole derivatives as pesticides
07/20/2005CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
07/20/2005CN1642917A Non-peptide GnRH antagonists
07/20/2005CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors
07/20/2005CN1642913A Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially CCR5)
07/20/2005CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642911A Phthalimido derivatives as inhibitors of monoamine oxidase B
07/20/2005CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642906A Novel arylamidine derivative or salt thereof
07/20/2005CN1642600A 1, 2-dihydropyrazol-3-ones which controls inflammatory cytokines
07/20/2005CN1642599A ACC inhibitors
07/20/2005CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
07/20/2005CN1642552A 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
07/20/2005CN1642551A Inhibitors of histone deacetylase
07/20/2005CN1642422A 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
07/20/2005CN1211381C Substituted imidazoles useful in treatment of inflammatory diseases
07/20/2005CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
07/20/2005CN1211367C Prostaglandin agonists and their use to treat bone disorders
07/20/2005CN1211362C New benzothiophene, benzofuran and indole compounds, process for their preparation and pharmaceutical compounds containing them
07/20/2005CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors
07/19/2005US6919482 A 1,4-bis(N-(2-(4-hydroxy-3-hydroxymethylphenyl) -2-hydroxyethyl)amino)-cyclohexane or alkyl-cyclohexane or -pyrazine derivatives; treating respiratory diseases disorders, asthma, bronchitis, nervous system injury
07/19/2005US6919461 Anticancer agents; antiarthritic agents
07/19/2005US6919459 Chemical intermediate oxidation, extraction with aqueous alkaline solution by controlling pH, removing by-product, purification; preparing proton pump inhibitors such as rabeprazole, omeprazole, pantoprazole, lansoprazole
07/19/2005US6919457 3-(imidazolyl)-2-aminopropanoic acids
07/19/2005US6919368 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
07/19/2005US6919359 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
07/19/2005US6919356 Antihistamines, antiallergens, autoimmune disease, antiinflammatory agents
07/19/2005US6919355 Amide derivatives as NMDA receptor antagonists
07/19/2005US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents
07/19/2005US6919351 Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors
07/19/2005US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
07/19/2005US6919344 Heterocyclic amines such as N-(Pyridin-4-yl)-(1-(4-fluoro-benzyl)indol-3-yl)glyoxylamide, used for prophylaxis of skin disorders, rheumatic diseases or arthritis
07/19/2005US6919339 ABCA-1 elevating compounds
07/19/2005US6919336 Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of IL-1 and TNF
07/19/2005US6919332 Enzyme inhibitors such as 5-(2-Methoxy-ethyl)-5-(4-(1-pyridin -3-yl-1H-indazol-5-yloxy)-phenoxy)-pyrimidine-2,4,6-trione, used as antiinflammatory and anticarcinogenic agents
07/19/2005US6919331 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
07/19/2005US6919178 Extended tethering approach for rapid identification of ligands
07/14/2005WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds
07/14/2005WO2005063754A1 Triazole derivatives as vasopressin antagonists
07/14/2005WO2005063739A1 Novel quinoline derivatives
07/14/2005WO2005063738A1 Novel 2-heteroaryl-substituted benzimidazole derivative
07/14/2005WO2005063737A1 Amidopyrazole derivative
07/14/2005WO2005063736A1 Aminoalkylpyrazole derivative
07/14/2005WO2005063735A1 2-(hetero)-aryl-substituted tetrahydroquinoline derivatives
07/14/2005WO2005063721A1 Herbicidal pyrimidines
07/14/2005WO2005063720A1 Amide derivative and medicine
07/14/2005WO2005063716A1 Imidazoles and their use cck-1 receptor modulators
07/14/2005WO2005063709A1 Amide derivative and medicine
07/14/2005WO2005063704A1 Azetidine ring compounds and drugs comprising the same
07/14/2005WO2005063690A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
07/14/2005WO2005063250A1 Neutrophilia inhibitor
07/14/2005WO2005063247A1 Aryl sulfonamide compounds and uses related thereto
07/14/2005WO2005063244A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies
07/14/2005WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
07/14/2005WO2005063020A1 Plant growth regulation
07/14/2005WO2005056550A3 Heterocyclic anti-migraine agents
07/14/2005WO2005049579A3 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
07/14/2005WO2005037781A3 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
07/14/2005WO2004098528A3 Pyrazole-amine compounds useful as kinase inhibitors
07/14/2005US20050154210 Obtaining a 2-oxo,3-substituted phenoxy-1,2-dihydropyridine by reacting a malonoaldehyde derivative, e.g., 3-alkoxypropenal, and a 2-substituted phenoxy,3-oxobutramide in the presence of a protonic acid; chemical intermediates for drugs and agricultural product, especially herbicides
07/14/2005US20050154204 Thioether-substituted benzamides as inhibitors of factor Xa
07/14/2005US20050154202 Substituted aryl amides
07/14/2005US20050154185 Vitronectin receptor antagonist pharmaceuticals
07/14/2005US20050154042 N-alkyl pyrroles as HMG-CoA reductase inhibitors
07/14/2005US20050154040 Nitrogen-containing heteroaryl derivatives
07/14/2005US20050154039 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
07/14/2005US20050154038 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia
07/14/2005US20050154028 1-(3-Fluoro-phenyl)-3-[4-methoxy-3-(2-piperidin-1-yl-ethoxy)-phenyl]-imidazolidin-2-one; serotonin 5-ht2c receptor antagonist; antidepressant and anxiolytic agent
07/14/2005US20050154027 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists